Application

19686394 · METHODS FOR REDUCING EOSINOPHILIC INFILTRATION BY ADMINISTERING AN ANTI-INTERLEUKIN-4 RECEPTOR (IL4R) ANTIBODY

Filed 2026-05-22 · Pending The official file ↗ · Art unit 1647 · Examiner Robert S Landsman Easy · CPC A61K 39/395 · Regeneron Pharmaceuticals, Inc. · CHOATE/REGENERON

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

2.2 mo

to disposition n/a

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.